CV Sciences, Inc.
CVSI$6M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
CVSI News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
CVT-E002 (Cold-FX); a natural health product
Upper Respiratory Infection
CVT E002 (Cold-fX)
Healthy
HT1001 extract of Panax quinquefolius L
Memory
CVT-E002 ginseng extract
Upper Respiratory Infection
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CVT-E002 (Cold-FX); a natural health product | Phase 3 | Upper Respiratory Infection | - | - |
CVT E002 (Cold-fX) | Phase 2 | Healthy | - | - |
HT1001 extract of Panax quinquefolius L | Phase 2 | Memory | - | - |
CVT-E002 ginseng extract | Phase 2 | Upper Respiratory Infection | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply